Japan's biggest drugmaker Takeda Pharmaceutical posted third-quarter profits on Thursday that trailed analyst estimates but ...

Well that won't be a problem in this mock. For our one-QB Dynasty start-up mock we had six Fantasy Football analysts and six of my followers from Twitter. Hopefully, you enjoy this mix.

Some players don't want an adventure to end no matter if the game is ten hours or a hundred. Dynasty Warriors: Origins has a post-game with some pretty incredible mechanics that unlock from weapon ...

With spring training on the horizon, the Rotoworld crew put out the call – picture Ron Burgundy’s iconic news team, assemble moment – and 15 fearless industry experts answered the call to participate ...

For the first time in a long time, Ja'Marr Chase and Justin Jefferson are not sharing a tier in my Dynasty Wide Receiver Tiers below. In fact, Chase has a tier to himself as the number one wide ...

If you’re eagerly awaiting Dynasty Warriors Origins, which launches on January 17, 2025, you can sharpen your skills with some of the most engaging action games available. Each of these titles ...

Takeda Pharmaceutical said on Thursday its CEO Christophe Weber will retire after more than a decade at the helm of Japan's ...

Neurocrine Biosciences (NBIX) announced it has amended its agreement with Takeda (TAK) to develop and commercialize osavampator. Under the amended agreement, Neurocrine will obtain exclusive ...

Stifel Nicolaus analyst Paul Matteis has maintained their bullish stance on NBIX stock, giving a Buy rating on January 24. Paul Matteis has given his Buy rating due to a combination of factors ...

Takeda Canada Inc. (Takeda) is pleased to announce that Héma-Québec has added HyQvia®– (normal immunoglobulin [human] 10% and recombinant human hyaluronidase solution for subcutaneous ...